{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T13:57:44Z","timestamp":1791986264613,"version":"4.4.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.vaccine.2018.10.066","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T14:38:22Z","timestamp":1540391902000},"page":"7509-7519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Towards a subunit vaccine from a Shigella flexneri \u0394tolR mutant"],"prefix":"10.1016","volume":"36","author":[{"given":"Yadira","family":"Pastor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Isabel","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaia","family":"Z\u00fa\u00f1iga-Ripa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aritz","family":"Merch\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Rosas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan M.","family":"Irache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6586-4657","authenticated-orcid":false,"given":"Carlos","family":"Gamazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2018.10.066_b0005","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyq035","article-title":"sanitation and hygiene for the prevention of diarrhoea","volume":"39","author":"Cairncross","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0010","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(17)30276-1","article-title":"Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015","volume":"17","author":"Bill","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"10.1016\/j.vaccine.2018.10.066_b0015","first-page":"651","article-title":"Global burden of Shigella infections: implications for vaccine development and implementation of control strategies","volume":"77","author":"Kotloff","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2018.10.066_b0020","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/lam.12690","article-title":"Update on: shigella new serogroups\/serotypes and their antimicrobial resistance","volume":"64","author":"Muthuirulandi Sethuvel","year":"2017","journal-title":"Lett Appl Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0025","doi-asserted-by":"crossref","first-page":"8222","DOI":"10.1016\/j.vaccine.2011.08.121","article-title":"Mucosal immunization with Shigella flexneri outer membrane vesicles induced protection in mice","volume":"29","author":"Camacho","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2018.10.066_b0030","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.resmic.2004.04.007","article-title":"Improved methods for producing outer membrane vesicles in Gram-negative bacteria","volume":"155","author":"Henry","year":"2004","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0035","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.000527","article-title":"Effective protection of mice against Shigella flexneri with a new self-adjuvant multicomponent vaccine","volume":"66","author":"Pastor","year":"2017","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0040","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/S0923-2508(01)01226-8","article-title":"The Tol-Pal proteins of the Escherichia coli cell envelope: an energized system required for outer membrane integrity?","volume":"152","author":"Lloub\u00e8s","year":"2001","journal-title":"Res Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1046\/j.1365-2958.2002.02895.x","article-title":"The Tol\/Pal system function requires an interaction between the C-terminal domain of TolA and the N-terminal domain of TolB","volume":"44","author":"Walburger","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0050","doi-asserted-by":"crossref","first-page":"26675","DOI":"10.1074\/jbc.M115.671586","article-title":"Structure and function of the Escherichia coli Tol-Pal stator protein TolR","volume":"290","author":"Wojdyla","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.vaccine.2018.10.066_b0055","doi-asserted-by":"crossref","first-page":"4717","DOI":"10.1128\/AEM.00640-07","article-title":"Development of a novel genetic system to create markerless deletion mutants of Bdellovibrio bacteriovorus","volume":"73","author":"Steyert","year":"2007","journal-title":"Appl Environ Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-2836(67)80070-6","article-title":"DNA replication and the division cycle in Escherichia coli","volume":"23","author":"Clark","year":"1967","journal-title":"J Mol Biol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0065","unstructured":"Mershon-Shiera KL, Vasuthasawata A, Takahashib KL, SM, Beenhouwer OD. In vitro C3 deposition on Cryptococcus capsule occurs via multiple complement activation pathways 2018;48:2009\u201318. doi:10.1016\/j.molimm.2011.06.215.In."},{"key":"10.1016\/j.vaccine.2018.10.066_b0070","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.ymeth.2012.09.008","article-title":"Towards a non-living vaccine against Shigella flexneri: from the inactivation procedure to protection studies","volume":"60","author":"Camacho","year":"2013","journal-title":"Methods"},{"issue":"1","key":"10.1016\/j.vaccine.2018.10.066_b0075","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/0769-2609(87)90051-2","article-title":"Evidence of heterogeneity of lipopolysaccharides among Brucella biovars in relation to A and M specificities","volume":"138","author":"Dubray","year":"1987","journal-title":"Ann Inst Pasteur Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0080","first-page":"83","article-title":"Bacterial lipopolysaccharides. Extraction with phenol-water and further applications of the procedure","author":"Westphal","year":"1965","journal-title":"Methods Carbohydr Chem"},{"key":"10.1016\/j.vaccine.2018.10.066_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-017-09481-x","article-title":"Olfactory bulb neuroproteomics reveals a chronological perturbation of survival routes and a disruption of prohibitin complex during Alzheimer\u2019s disease progression","volume":"7","author":"Lach\u00e9n-Montes","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.vaccine.2018.10.066_b0090","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jprot.2016.07.032","article-title":"An early dysregulation of FAK and MEK\/ERK signaling pathways precedes the \u03b2-amyloid deposition in the olfactory bulb of APP\/PS1 mouse model of Alzheimer\u2019s disease","volume":"148","author":"Lach\u00e9n-Montes","year":"2016","journal-title":"J Proteomics"},{"key":"10.1016\/j.vaccine.2018.10.066_b0095","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1074\/mcp.T600050-MCP200","article-title":"The paragon algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra","volume":"6","author":"Shilov","year":"2007","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/j.vaccine.2018.10.066_b0100","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1021\/pr070492f","article-title":"Nonlinear fitting method for determining local false discovery rates from decoy database searches","volume":"7","author":"Tang","year":"2008","journal-title":"J Proteome Res"},{"key":"10.1016\/j.vaccine.2018.10.066_b0105","doi-asserted-by":"crossref","DOI":"10.1038\/nri3837","article-title":"Immune modulation by bacterial outer membrane vesicles","volume":"15","author":"Kaparakis-Liaskos","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0110","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40265-013-0155-7","article-title":"A multi-component meningococcal serogroup B vaccine (4CMenB): The clinical development program","volume":"74","author":"O\u2019Ryan","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.vaccine.2018.10.066_b0115","doi-asserted-by":"crossref","DOI":"10.1002\/biot.201400395","article-title":"Outer membrane vesicles as platform vaccine technology","author":"van der Pol","year":"2015","journal-title":"Biotechnol J"},{"key":"10.1016\/j.vaccine.2018.10.066_b0120","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1128\/JB.180.18.4872-4878.1998","article-title":"Escherichia coli tol-pal mutants form outer membrane vesicles","volume":"180","author":"Bernadac","year":"1998","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0125","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/hel.12196","article-title":"Increased outer membrane vesicle formation in a Helicobacter pylori tolB mutant","volume":"20","author":"Turner","year":"2015","journal-title":"Helicobacter"},{"issue":"15","key":"10.1016\/j.vaccine.2018.10.066_b0130","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1016\/j.vaccine.2016.02.018","article-title":"Development of a cost-effective vaccine candidate with outer membrane vesicles of a tolA-disrupted Shigella boydii strain","volume":"34","author":"Mitra","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2018.10.066_b0135","doi-asserted-by":"crossref","unstructured":"Scorza FB, Colucci AM, Maggiore L, Sanzone S, Rossi O, Ferlenghi I, et al. High yield production process for shigella outer membrane particles 2012;7. doi:10.1371\/journal.pone.0035616.","DOI":"10.1371\/journal.pone.0035616"},{"key":"10.1016\/j.vaccine.2018.10.066_b0140","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.femsre.2004.09.003","article-title":"The interaction between bacteria and bile","volume":"29","author":"Begley","year":"2005","journal-title":"FEMS Microbiol Rev"},{"key":"10.1016\/j.vaccine.2018.10.066_b0145","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1128\/JB.145.3.1351-1358.1981","article-title":"Genetic and biochemical characterization of periplasmic-leaky mutants of Escherichia coli K-12","volume":"145","author":"Lazzaroni","year":"1981","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0150","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1099\/mic.0.046565-0","article-title":"TolA mediates the differential detergent resistance pattern between the Salmonella enterica subsp. enterica serovars Typhi and Typhimurium","volume":"157","author":"Lahiri","year":"2011","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2018.10.066_b0155","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1371\/journal.pone.0103784","article-title":"The periplasmic protein TolB as a potential drug target in Pseudomonas aeruginosa","volume":"9","author":"Lo Sciuto","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2018.10.066_b0160","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1128\/IAI.11.2.273-279.1975","article-title":"Interaction of complex polysaccharides with the complement system: effect of calcium depletion on terminal component consumption","volume":"11","author":"Snyderman","year":"1975","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.10.066_b0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fcimb.2016.00040","article-title":"Defining the binding region in factor H to develop a therapeutic factor H-Fc fusion protein against non-typeable Haemophilus influenzae","volume":"6","author":"Wong","year":"2016","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0170","doi-asserted-by":"crossref","first-page":"7566","DOI":"10.4049\/jimmunol.176.12.7566","article-title":"Functional significance of factor H binding to Neisseria meningitidis","volume":"176","author":"Schneider","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0175","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1365-2958.2002.02997.x","article-title":"StcE, a metalloprotease secreted by Escherichia coli O157:H7, specifically cleaves C1 esterase inhibitor","volume":"45","author":"Lathem","year":"2002","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0180","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.molimm.2006.06.011","article-title":"Bacterial complement evasion","volume":"44","author":"Rooijakkers","year":"2007","journal-title":"Mol Immunol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0185","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/infdis\/jiv013","article-title":"The serine protease Pic from enteroaggregative Escherichia coli mediates immune evasion by the direct cleavage of complement proteins","volume":"212","author":"Abreu","year":"2015","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2018.10.066_b0190","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4049\/jimmunol.118.1.362","article-title":"Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS)","volume":"118","author":"Morrison","year":"1977","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0195","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.1108472","article-title":"Optimization of virulence functions through glucosylation of Shigella LPS","volume":"307","author":"West","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2018.10.066_b0200","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1128\/JB.188.7.2735-2739.2006","article-title":"Altering the length of the lipopolysaccharide O antigen has an impact on the interaction of Salmonella enterica serovar typhimurium with macrophages and complement","volume":"188","author":"Murray","year":"2006","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0205","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1086\/338269","article-title":"Complement activation induced by purified Neisseria meningitidis lipopolysaccharide (LPS), outer membrane vesicles, whole bacteria, and an LPS-free mutant","volume":"185","author":"Bjerre","year":"2002","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2018.10.066_b0210","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1128\/IAI.00682-10","article-title":"Lipoproteins of bacterial pathogens","volume":"79","author":"Kovacs-Simon","year":"2011","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.10.066_b0215","doi-asserted-by":"crossref","unstructured":"Schroeder GN, Hilbi H. Molecular pathogenesis of shigella spp.: controlling host cell signaling, invasion, and death by type III secretion 2008;21:134\u201356. doi:10.1128\/CMR.00032-07.","DOI":"10.1128\/CMR.00032-07"},{"key":"10.1016\/j.vaccine.2018.10.066_b0220","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.vetmic.2012.08.019","article-title":"The OmpA family of proteins: Roles in bacterial pathogenesis and immunity","volume":"163","author":"Confer","year":"2013","journal-title":"Vet Microbiol"},{"issue":"Pt 7","key":"10.1016\/j.vaccine.2018.10.066_b0225","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1099\/00221287-144-7-1815","article-title":"SepA, the 110 kDa protein secreted by Shigella flexneri: two-domain structure and proteolytic activity","volume":"144","author":"Benjelloun-Touimi","year":"1998","journal-title":"Microbiology"},{"key":"10.1016\/j.vaccine.2018.10.066_b0230","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/mmi.12609","article-title":"Polar localization of Escherichia coli chemoreceptors requires an intact Tol-Pal complex","volume":"92","author":"Santos","year":"2014","journal-title":"Mol Microbiol"},{"issue":"18","key":"10.1016\/j.vaccine.2018.10.066_b0235","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1021\/bi400164t","article-title":"Envelope control of outer membrane vesicle production in gram-negative bacteria","volume":"52","author":"Schwechheimer","year":"2013","journal-title":"Biochemistry"},{"key":"10.1016\/j.vaccine.2018.10.066_b0240","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/JB.184.3.754-759.2002","article-title":"Pal lipoprotein of Escherichia coli plays a major role in outer membrane integrity","volume":"184","author":"Cascales","year":"2002","journal-title":"J Bacteriol"},{"key":"10.1016\/j.vaccine.2018.10.066_b0245","doi-asserted-by":"crossref","first-page":"4005","DOI":"10.1128\/IAI.65.10.4005-4010.1997","article-title":"Secretion of Ipa proteins by Shigella flexneri: inducer molecules and kinetics of activation","volume":"65","author":"Bahrani","year":"1997","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2018.10.066_b0250","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1574-695X.2012.01004.x","article-title":"Outer membrane vesicles of Shigella boydii type 4 induce passive immunity in neonatal mice","volume":"66","author":"Mitra","year":"2012","journal-title":"FEMS Immunol Med Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X18314348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T09:48:32Z","timestamp":1693993712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X18314348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":50,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S0264410X18314348"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.066","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards a subunit vaccine from a Shigella flexneri \u0394tolR mutant","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}